Skip to content
Ella, Ellaone(ulipristal)
Ella, Esmya, ellaOne (ulipristal) is a small molecule pharmaceutical. Ulipristal was first approved as Ellaone on 2009-05-15. It has been approved in Europe to treat leiomyoma and postcoital contraception. The pharmaceutical is active against progesterone receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
therapeuticsD013812
Trade Name
FDA
EMA
Ella (generic drugs available since 2017-02-13)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ulipristal acetate
Tradename
Company
Number
Date
Products
ELLAHRA PharmaN-022474 RX2010-08-13
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
ellaNew Drug Application2023-02-15
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
ULIPRISTAL ACETATE, ELLA, LAB HRA PHARMA
2024-06-24M-271
Patent Expiration
Patent
Expires
Flag
FDA Information
Ulipristal Acetate, Ella, Lab Hra Pharma
84263922030-06-12U-1389
89626032030-06-12U-1657
85127452030-06-02DP
92832332030-04-13U-1821
101596812030-04-13U-2510
107728972030-04-13U-2958
87353802029-02-20DP
98445102028-12-08DP
ATC Codes
G: Genito urinary system and sex hormones
G03: Sex hormones and modulators of the genital system
G03A: Hormonal contraceptives for systemic use
G03AD: Emergency contraceptive drugs
G03AD02: Ulipristal
G03X: Other sex hormones and modulators of the genital system in atc
G03XB: Progesterone receptor modulators, sex hormones and modulators of the genital system
G03XB02: Ulipristal
HCPCS
No data
Clinical
Clinical Trials
67 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeiomyomaD007889HP_0000131D251359321
ContraceptionD0032674422315
Postcoital contraceptionD04436313115
InfertilityD007246EFO_0000545112
AdenomyosisD062788EFO_1001757N80.0112
MenorrhagiaD008595N92.022
Contraception behaviorD003268112
DysmenorrheaD004412HP_0100607N94.611
EndometriosisD004715EFO_0001065N8011
Pancreatic neoplasmsD010190EFO_0003860C2511
Show 3 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Uterine hemorrhageD01459222
HemorrhageD006470MP_0001914R5811
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovulation inhibitionD034445111
Breast neoplasmsD001943EFO_0003869C5011
Female genital diseasesD005831EFO_0009549N8511
Premenstrual dysphoric disorderD065446F32.8111
Premenstrual syndromeD011293N94.311
DepressionD003863F33.911
PostmenopauseD01769811
Missed abortionD000030O02.111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urogenital abnormalitiesD01456411
Lung transplantationD01604011
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Female infertilityD007247EFO_0008560N9722
Tracheal stenosisD01413511
Unplanned pregnancyD04916811
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameULIPRISTAL
INNulipristal
Description
Ulipristal acetate is a 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. It has a role as a contraceptive drug, a progestin and a progesterone receptor modulator. It is a 3-oxo-Delta(4) steroid, a steroid ester, an acetate ester, a 20-oxo steroid and a tertiary amino compound. It is functionally related to an estradiol.
Classification
Small molecule
Drug classsteriodal compounds acting on progesterone receptors (excluding-gest- compounds)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
Identifiers
PDB
CAS-ID126784-99-4
RxCUI1005920
ChEMBL IDCHEMBL2103846
ChEBI ID
PubChem CID130904
DrugBankDB08867
UNII ID6J5J15Q2X8 (ChemIDplus, GSRS)
Target
Agency Approved
PGR
PGR
Organism
Homo sapiens
Gene name
PGR
Gene synonyms
NR3C3
NCBI Gene ID
Protein name
progesterone receptor
Protein synonyms
Nuclear receptor subfamily 3 group C member 3
Uniprot ID
Mouse ortholog
Pgr (18667)
progesterone receptor (Q00175)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 942 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6,985 adverse events reported
View more details